Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local bupivacaine for post-appendectomy pain
IRCT20190126042493N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine in acute appendicitis and postoperative pain (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Pain severity. Started Feb 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
acute appendicitispostoperative pain
Beyond the preview
Go deeper on IRCT20190126042493N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190126042493N1.